Publication | Closed Access

Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia

InflammationVascular Inflammation/dysfunctionAnti-inflammatoryLipopolysaccharide‐induced EndotoxemiaVascular PharmacologyImmunologyPharmacologyChronic InflammationEndothelial DysfunctionVascular BiologyMedicineTreatment Improves Survival